Successful $5million Placement
Released
Released
Announcement PDF
12 May 2025
Andromeda Metals Limited ASX: ADN
ASX Announcement
10/431 King William Street
Adelaide, SA 5000
Tel:+61 8 7089 9800
ir@andromet.com.au
ABN
75 061 503 375
Successful $5 million Placement
Key Highlights:
•
Strong demand, with significant interest from new institutional investors
• Allows pre-FID early works to advance the Great White Project
• Accelerates advancement of HPA project
Andromeda Metals Limited (ASX: ADN) (Andromeda, the Company) is pleased to announce that it
has successfully undertaken a placement of new fully paid ordinary shares (Placement) raising
approximately $5 million before costs.
Firm commitments for 384.6 million new fully paid ordinary shares have been received from institutional
and sophisticated investors (New Shares) at $0.013 per New Share, after the offer was in strong
demand, resulting in applications being scaled-back.
The price of $0.013 per New Share, represents a discount of 23.5% to the previous closing price of $0.017
(Wednesday, 7 May 2025). The Placement shares will come within the Company’s placement
capacity under Listing Rule 7.1.
Placement participants will also receive 3 free attaching options for every 4 New Shares allocated
(New Options), subject to shareholder approval. Each New Option is exercisable at $0.0195 for a fully
paid ordinary share, expiring 2 years from the date of issue and otherwise on the terms set out in
Annexure 1. Application will be made for quotation of New Options on ASX. If exercised, these New
Options will provide an additional $5.6 million in working capital for the Company.
The Company is pleased by the strong support shown from these new investors and welcomes them
as shareholders of the Company.
Funds raised will be used to progress:
•
The Great White Project, including early works, advanced plant design and engineering, and
technical, financial and legal activities to support the funding process for project
development;
•
The Company’s HPA project, including the Scoping Study and product and market
development activities; and
•
General working capital and the costs of the Placement.
The placement of New Shares will be issued in accordance with Andromeda’s placement capacity
under ASX Listing Rule 7.1 and shareholder approval will be sought for the issue of the New Options at
a General Meeting (to be scheduled).
Settlement of the Placement is scheduled to occur on Monday 19 May 2025, with issue of the New
Shares under the Placement scheduled to occur on Tuesday 20 May 2025. New Options will only be
issued after shareholder approval is obtained.
Bell Potter and Canaccord Genuity are Joint Lead Managers to the Placement and are entitled to a
fee of 6% on the funds raised, plus the issue of 5,000,000 options on the same terms as the New Options.
The broker options will come within the Company’s placement capacity under Listing Rule 7.1.
Sarah Clarke, Andromeda’s Acting Chief Executive Officer said:
“We have experienced growing interest from a range of new investors seeking to invest in Andromeda,
following recent announcements regarding the progress of our development funding process and our
HPA breakthrough results.
“The significant interest saw robust demand in this Placement, demonstrating strong investor
confidence in Andromeda’s future.
“The funds raised from this capital raising will enable us to progress our Great White Project in
anticipation of a final investment decision, including advanced plant design and early engineering
works for Stage 1A+.
“The funds will also allow us to further progress our HPA project, through the completion of a Scoping
Study and product development and marketing activities.
“The strong support for this Placement and the increased investor participation leaves Andromeda
well placed to advance the Stage 1A+ project to a final investment decision while also progressing
development of the exciting HPA opportunity.”
Capital Structure
The capital structure of the Company on successful completion of the Placement is expected to be
as follows:
Number
of
Number of Quoted Options
Number
Shares
of
Unquoted Options
Number
of
Performance
Rights
As at the date
3,430,700,478
of this
338,440,053
exercisable
at
46,071,669
32,791,700
at
Nil
Nil
46,071,669
32,791,700
$0.0175 and expiry 30 Sep 27
announcement
To be issued
384,615,385
293,461,539
exercisable
under the
$0.0195 expiring 2 years after
Placement
issue
Total Number
3,815,315,863
631,901,591
on issue after
the Placement
Andromeda Metals Limited | 2
Timetable
The indicative timetable for the Placement is as follows:
Event
Date
Placement Announced
Monday 12 May 2025
Settlement of Placement
Monday 19 May 2025
Allotment and Trading of New Shares
Tuesday 20 May 2025
Extraordinary General Meeting
June 2025
Allotment and Trading of New Options (subject to
Following shareholder approval
admission to quotation)
Dates and times are indicative only and are subject to change. Any material changes will be notified
to ASX. All dates and times are references to AEST, Australia time.
The trading halt can now be lifted.
This announcement has been approved for release by the Board of Andromeda Metals Limited.
For more information about the Company and its projects, please visit our website,
www.andromet.com.au or contact:
Manager, Investor Relations & Corporate Affairs
Patrick Sinclair
T: 08 7089 9819
M: 0403 708 431
E: Patrick.Sinclair@andromet.com.au
FORWARD-LOOKING STATEMENTS
This document contains or may contain certain forward-looking statements and comments about future events, that
are based on Andromeda's beliefs, assumptions and expectations and on information currently available to
management as at the date of this document. Often, but not always, forward-looking statements can generally be
identified by the use of forward-looking words such as "may", "will", "expect", "plan", "believes", "estimate", "anticipate",
"outlook", and "guidance", or similar expressions. Such statements are only expectations or beliefs and are subject to
inherent risks and uncertainties which could cause actual values, results or performance achievements to differ
materially from those expressed or implied in this presentation. Where Andromeda expresses or implies an expectation
or belief as to future events or results, such expectation or belief is expressed in good faith and on a reasonable basis.
No representation or warranty, express or implied, is made by Andromeda that the matters stated in this presentation
will in fact be achieved or prove to be correct. Except as required by law, Andromeda undertakes no obligation to
provide any additional or updated information or update any forward-looking statements, whether on a result of new
information, future events, results or otherwise. Readers are cautioned against placing undue reliance on forwardlooking statements. These forward-looking statements are not guarantees of future performance and involve known
and unknown risks, uncertainties, assumptions and other important factors, many of which are beyond the control of
Andromeda, the directors, and management of Andromeda.
Andromeda Metals Limited | 3
Annexure 1 – Option Terms
The New Options (including the options to be issued to the brokers) are all in the same class and will
be issued on the following terms and conditions:
(a)
Entitlement
Each Option entitles the holder to acquire by way of issue one Share on exercise of the
Option.
(b)
Exercise Price
Subject to paragraph (h) below, the exercise price of the Options will be $0.0195 (Exercise
Price).
(c)
Expiry Date
Each Option will expire at 5.00pm (AEST) 2 years after the date of issue. An Option not
exercised by the Expiry Date will automatically lapse at that time at that time.
(d)
(e)
(f)
Exercise Period
The Options are exercisable at any time on or prior to the Expiry Date (Exercise Period).
Notice of Exercise
A Notice of Exercise is only effective on and from the later of the date of receipt of the
Notice of Exercise and the date of receipt of the payment of the applicable Exercise Price
for each Option being exercised in cleared funds (Exercise Date).
A minimum of 100,000 Options may be exercised under each Notice of Exercise. If a
Shareholder holds less than 100,000 Options, all of the Options held by them must be
exercised in one Notice of Exercise.
Timing of issue of Shares on exercise
As soon as practicable after the Exercise Date, the Company will:
(i)
(g)
(h)
(i)
(j)
(k)
issue the number of Shares required under these terms and conditions in respect of
the number of Options specified in the Notice of Exercise and for which cleared
funds have been received by the Company; and
(ii)
if admitted to the Official List at the time, apply for official quotation on ASX of
Shares issued on the exercise of the Options.
Shares issued on exercise
Shares issued on exercise of the Options will rank equally in all respects with the then issued
Shares.
Reconstruction of capital
If at any time the issued capital of the Company is reconstructed, all rights of a holder of
Options are to be changed in a manner consistent with the Corporations Act, the ASX
Listing Rules and any other applicable laws or regulations at the time of the reconstruction.
Participation in new issues
There are no participation rights or entitlements inherent in the Options and holders will not
be entitled to participate in new issues of capital offered to Shareholders during the
currency of the Options without exercising the Options and unless Shares have been issued
in respect of the Options before the record date for determining entitlements to the issue.
Change in Exercise Price
There will be no change to the applicable Exercise Price of an Option or the number of
Shares over which an Option is exercisable in the event of the Company making a pro
rata issue of Shares or other securities to the holders of Shares (other than for a Bonus
Issue).
Bonus issue
If before the expiry of any Options, the Company makes a pro rata issue of Shares to
Shareholders for no consideration (Bonus Issue), the number of Shares over which an
Option is exercisable will be increased by the number of Shares which the holder would
Andromeda Metals Limited | 4
(l)
(m)
have received if the Option had been exercised before the record date for the Bonus
Issue.
Transferability
The Options are transferable and application will be made for quotation on ASX.
Voting
Holders of Options have no voting rights until the Options are exercised and Shares issued
on exercise of those Options in accordance with the ASX Listing Rules.
Andromeda Metals Limited | 5
Share your feedback
Discover